Compound 48/80-induced permeability change in liposomal membrane  by Katsu, Takashi et al.
Volume 151, number 2 FEBS LETTERS January 1983 
Compound 48/80-induced permeability change 
in liposomal membrane 
Takashi Katsu, Kenji Tasaka and Yuzaburo Fujita 
Faculty of Pharmaceutical Sciences, Okayama University, Tsushima, Okayama 700, Japan 
Received 18 October 1982; revision received 6 December 1982 
The action of compound 48/80 (a mixture of condensation products ofp-methoxy-N-methylphenethylamine 
with formaldehyde) on liposomal membranes was studied by means of K+-loaded liposomes and a K+ 
ion-selective lectrode. Prompt efflux of K+ was detected when 48180 was added to the negatively charged 
liposome suspension, while the monomer of 48/80, p-methoxy-N-methylphenethylamine, did not release 
K+ from the same liposomes. The mechanism for the action of 48/80 is discussed in comparison with that 
of a polymyxin, well known as an antibiotic acting on bacterial membranes. 
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1. INTRODUCTION 
Compound 48/80 produces a potent histamine 
release from mast cells [l-3]. This compound is 
synthesized by condensing p-methoxy-N-methyl- 
phenethylamine with formaldehyde [4], and is 
thought to be a mixture of linear copolymers. Dia- 
lysis and gel filtration [5], and 13C NMR studies [6] 
have shown that the most active polymers are 
probably the hexamer (fig. 1). Although the detailed 
molecular mechanism of histamine release due to 
48180 has not yet been clarified, recent ESR studies 
using spin-labelled 48/80 have shown that an initial 
interaction may take place between 48/80 and 
anionic proteins on the surface membrane [7]. 
Aside from mast cells, several reports have des- 
cribed the effects of 48/80 not related to histamine 
secretion; one of the interesting actions of 48/80 is 
an antimicrobial activity, exhibited as the inhibi- 
Abbreviations: DPPC, dipalmitoylphosphatidylcholine; 
CHOL, cholesterol; DCP, dicetylphosphate; SA, stearyl- 
amine; HEPES, N-2-hydroxyethylpiperazine-N’-2-eth- 
anesulfonic acid 
PoIymyxin B 
tion of the growth of protozoa, bacteria, and fungi 
[B]. Such action of 48/80 is similar to that of a 
polymyxin, well known as an antibiotic [9]. The 
mechanism of the antimicrobial activity of the 
polymyxin has been discussed in detail [9], and the 
polymyxin is also known to release histamine, as in 
the case of 48/80 [lo]. The polymyxin molecule 
interacts preferentially with acidic phospholipid 
and lipopolysaccharide, and then alters the struc- 
ture and permeability of the bacterial membranes 
PI. 
We were interested in the structure-resemblance 
between 48180 and polymyxin; both are polycation 
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Fig.1. Structure of active constituent of 48180. 
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with an appropriate lipophilic character. This sug- 
gests that 48/80 may also interact with negatively 
charged lipid constituents of the membrane to 
induce the permeability changes. In this communi- 
cation, we report on the permeability change of 
liposomal membrane induced by 48/80. We re- 
ported the liposomes entrapped K+ as a marker, 
and the release of K+ was measured with a K+ ion- 
selective electrode (K+ ISE). It was found that the 
rapid efflux of K+ was observed when 48/80 mole- 
cules interacted with negatively charged liposomes. 
2. MATERIALS AND METHODS 
Liposomes were prepared as previously described 
[ll]. In brief, a dried thin film prepared with 
10 pmol DPPC and appropriate quantities of 
various other substances (CHOL, DCP or SA), 
with molar ratios as indicated in the text, was swol- 
len at 55°C in 0.15 M KC1 solution buffered with 
5 mM HEPES adjusted to pH 7.4 by addition of 
KOH. To remove the untrapped K+ marker, the re- 
sulting multilamellar liposomes were washed with a 
fresh HEPES-buffered isotonic salt solution 
(0.15 M NaCl plus 5 mM HEPES adjusted to 
pH 7.4 with NaOH) and centrifuged (22000 x g 
for 10 min) at lS”C, 6-times. The final pellet of 
liposomes was dispersed in 1 ml of NaCl-HEPES 
buffer to yield 10 mM phosphatidylcholine lipo- 
some suspension. The background level of K+ was 
reduced to lo-’ M. 
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Fig.2. Response of K+ ISE in NaCl-HEPES buffer 
(pH 7.4). 
A K+ ISE was constructed as in [ 111. Fig.2 shows 
the response of K+ ISE in NaCl-HEPES buffer. 
The electrode provided a Nernstian response from 
0.1-10-5 M of K+. The interference of 48180 on 
the electrode was negligible within the concentra- 
tion range studied. 
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3. RESULTS AND DISCUSSION 
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Fig.3 shows the effect of 48/80 on the K+ release 
from the liposomes prepared with DPPC, CHOL 
and DCP in a molar ratio of 1:0.75 : 0.1. Experi- 
ments were carried out at room temperature in a 
beaker (10 ml) containing 1 ml NaCl-HEPES buf- 
fer. Addition of a liposome aliquot (0.2 ml) pro- 
duced a slight increase of the K+ concentration due 
to the untrapped and remaining K+ in the suspen- 
sion. Addition of 0.1 ml of 48/80 (5 x 10e6 g) 
induced a rapid increase of the K+ concentration. 
Fig.3. Potential change due to K+ release upon addition 
of 48/80. At zero time, 0.2 ml of liposome aliquot (pre- 
pared from DPPC, CHOL and DCP in a molar ratio 
1: 0.75 : 0.1) was added to 1 ml of NaCl-HEPES buffer. 
After 3 min, 0.1 ml of 48/80 (containing 5 x 10m6 g) 
was added. 
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The dose response curve of 48/80 is shown in fig.4, 
along with those of the other two types of lipo- 
somes, prepared respectively with either stearyl- 
amine as a positively charged or uncharged lipid 
components. The results clearly demonstrate that 
liposomes made of lipid with negative charge are 
sensitive to 48/80, while the other liposomes made 
of positively charged lipid do not respond to 48/80. 
The figure also shows that the monomer of 48/80, 
p-methoxy-N-methylphenethylamine, did not pro- 
vode any release of K+ from the liposomes prepared 
with dicetylphosphate. 
In the range of temperature tested (8-38”(Z), the 
action of 48/80 showed the same rapid efflux of 
K+, though the rate became slightly slower at lower 
temperatures. In addition, K+ release was also 
observed in the liposomes without cholesterol at 
room temperature. These facts seem to indicate 
that 48/80 does not act as a carrier-type ionophore, 
facilitating the transport of ions by diffusion 
across the membrane, since the carrier-type iono- 
Concentration Of Q/80 (q/ml) 
Fig.4. Release of K+ from various liposomes by the 
action of 48/80. The percentage of K+ release was deter- 
mined from the marker efflux within 10 min after 48/80 
addition. The total amount of the K+ marker was deter- 
mined by disrupting the liposome with an ultrasonicator 
(Bransonic B-220, 125W) for 15 min at 55°C. Liposome 
composition (molar ratios): (M) DPPC, CHOL and 
DCP (1: 0.75 : 0.1); (M) DPPC and CHOL (1 : 0.75); 
(I--r) DPPC, CHOL and SA (1: 0.75 : 0.1). By addi- 
tion of the monomer of 48/80 (10m4 g), K+ was not 
released at all from the liposomes composed of DPPC, 
CHOL and DCP in a molar ratio of 1: 0.75 : 0.1. 
phore shows a marked temperature dependence 
[12]. In accordance with this assumption it has 
been demonstrated that when 48/80 coated Sepha- 
rose beads were exposed to mast cells, histamine 
release was provoked, similarly to the application 
of 48/80 in the solution [13]. 
The following reason for the K+ release is con- 
sidered. 48180 may easily be incorporated into the 
hydrophilic region of the liposomal membrane 
since it provides high solubility in alcoholic solu- 
tions and this process may be accelerated by the 
electrostatic interaction with negatively charged 
lipid molecules. Insertion of such highly ionized 
polymer into the lipid bilayers may cause some 
region in which lipid arrangement in the membrane 
will be disordered, thus results in the K+ release 
from the liposomes. The membrane disorder as a 
result of the interaction with negatively charged 
lipids has also been discussed in the action of poly- 
myxin with biological and artificial membranes 
[9,14]. However, the most remarkable difference 
in the action of both compounds depends on the 
composition of liposomes. Little K+ release was 
observed with 7.7 x 10e6 g/ml of polymyxin B 
from the liposomes with the same composition 
(DPPC, CHOL and DCP in a ratio of 1: 0.75 : 0.1); 
this result is consistent with the observation carried 
out with glucose as a marker [15]. Without chol- 
esterol, polymyxin disrupts the lipid membrane 
effectively [15]. It seems to be reasonable to 
assume that the cholesterol molecule filled in the 
space between the lipid molecules may hinder the 
penetration of polymyxin molecule into mem- 
branes. Fig.5 shows the permeability change of the 
liposome composed of DPPC and DCP in a molar 
ratio of 1: 0.1. The time sequence of K+ release by 
polymyxin B was gradual compared with 48/80. 
This difference may be due to much lower solu- 
bility of polymyxin in phospholipid bilayer; the 
lower solubility of polymyxin in alcoholic solution 
may imply the poor incorporation of polymyxin in- 
to the hydrophilic region. Accordingly, the action 
of polymyxin is considered to be initiated by the 
electrostatic interaction with the negatively charg- 
ed lipid molecules. Then a hydrophobic paraffin 
tail penetrates gradually into the lipid bilayer, 
possibly inducing a deformation of the bilayer 
structure. 
It may be worthwhile to note here in order to 
explain the mechanism of the action of 48/80 fur- 
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Fig.5. Potential change due to K+ release upon addition 
of polymyxin B (a) and 48/80 (b). Liposomes were com- 
posed of DPPC and DCP in a molar ratio of 1 :O.l. 
Liposomes, and polymyxin B or 48/80 were added in the 
manner shown in fig.3. The same concentration of 48/80 
and of polymyxin B was applied (7.7 x 10m6 g/ml). 
ther, that the addition of lOpg/ml of 48180 has 
only induced 10% efflux of K+ marker (fig.4). This 
percentage corresponds to the amount of K+ en- 
trapped in the outermost envelope of multilamellar 
liposome [16], indicating that 48180 interacts only 
with the outermost membrane surface, while inner 
membranes are not effectively attacked. This obser- 
vation is of interest in relation to the initial 
stimulation of 48/80 on the mast cells. Below the 
concentration of lOpg/ml, the stimulation of 
48/80 on mast cells is known as a non-cytotoxic 
reaction, which is different from cytotoxic action, 
as produced by some detergents, for instance, 
Triton X-100 [17]. The finding that Triton X-100 
disrupts the multilamellar liposomes, releasing the 
majority of K+ entrapped, is in accordance with 
the toxic action of this compound on mast cells. In 
the case of mast cells, the non-cytotoxic action of 
48/80 has been initiated by the interaction with the 
acidic parts of proteins on the cytoplasmic mem- 
brane [7]. 
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